CLINICAL_TRIALS
trial_result
· 2024-05-08
Clinical Trial Update: Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis [Phase 3]
Summary
A Phase 3 trial comparing a stent to indomethacin for preventing post-ERCP pancreatitis has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: Post-ERCP Pancreatitis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-08